The amendments to this chapter made by the Modernization of Cosmetics Regulation Act of 2022, referred to in subsecs. (span) and (c), means the amendments made by subtitle E (§§ 3501–3508) of title III of div. FF of Puspan. L. 117–328, which enacted this section and sections 364 to 364i of this title and amended sections 331, 361, 362, 374, and 381 of this title.

The time of enactment of the Modernization of Cosmetics Regulation Act of 2022, referred to in subsec. (span), probably means the date of enactment of subtitle E (§§ 3501–3508) of title III of div. FF of Puspan. L. 117–328, which was approved Dec. 29, 2022.

Nothing in section 3502 of Puspan. L. 117–328, which enacted this section, to be construed to authorize the disclosure of information that is prohibited from disclosure under section 331(j) of this title or section 1905 of title 18 or that is subject to withholding under section 552(span)(4) of title 5, see section 3503(c)(2) of Puspan. L. 117–328, set out as a note under section 364 of this title.